Matthew D. Bryant

TL;DR: A model in mouse using a species-adapted virus recapitulates features of SARS-CoV-2 infection and age-related disease pathogenesis in humans, and provides a model system for rapid evaluation of medical countermeasures against coronavirus disease 2019 (COVID-19).

TL;DR: This mouse-adapted SARS-CoV-2 model demonstrates age-related disease pathogenesis and supports the clinical use of IFN lambda-1a treatment in human COVID-19 infections and shows that clinical candidate interferon (IFN) lambda- 1a can potently inhibit SARS's replication in primary human airway epithelial cells in vitro and both prophylactic and therapeutic administration diminished replication in mice.

TL;DR: A Correction to this paper has been published: https://doi.org/10.1038/s41586-020-03107-5

TL;DR: The authors conducted a qualitative study to assess the management of Celiac disease (CeD) among US GI, and found that compliance with a Gluten Free Diet (GFD) is the biggest challenge for many patients, which is of concern in about 40% of patients.